Caricamento...

Inhibition of amyloid-β production by anti-amyloid precursor protein antibodies in primary mouse cortical neurones

Current therapies for Alzheimer’s disease (AD) only treat the symptoms of the disease. We have previously developed a novel monoclonal antibody, 2B3, which binds to the β-secretase cleavage site in amyloid precursor protein (APP) and reduces the production of amyloid-β (Aβ) in human cell lines. To d...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Neuroreport
Autori principali: Thomas, Rhian S., Hvoslef-Eide, Martha, Good, Mark A., Kidd, Emma J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4493351/
https://ncbi.nlm.nih.gov/pubmed/24145776
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/WNR.0000000000000055
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !